| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 05/03/1989 | EP0314042A2 Novel copolymers and superoxide dismutase modified with said copolymers |
| 05/03/1989 | EP0313874A2 Disulfur analogs of LL-E33288 antitumor agents |
| 05/03/1989 | EP0313873A1 Targeted forms of methyltrithio antitumor agents |
| 05/03/1989 | EP0313845A1 Stabilization of enteric coated dosage form |
| 05/03/1989 | DE3735777A1 Carrier-bound mono- or polyclonal antibody |
| 05/02/1989 | US4827062 Composition containing ubidecarenone with absorption promoted |
| 05/02/1989 | US4827003 Hemiacetal compounds and the applications thereof |
| 05/02/1989 | US4826963 Dissolving absorption |
| 05/02/1989 | US4826945 Biodegradable polymeric materials based on polyether glycols, processes for the preparation thereof and surgical articles made therefrom |
| 05/02/1989 | US4826830 Topical application of glyciphosphoramide |
| 05/02/1989 | US4826825 Foods, drugs, cosmetics, chemicals, dessication |
| 05/02/1989 | US4826817 Amino acid and hydroxyamino acid transporter compounds for therapeutic applications, process and use |
| 05/02/1989 | US4826700 Gelling agents and thickeners based on cassia-galactomannans |
| 05/02/1989 | US4826681 Anhydrous solution of hydrogen peroxide in an organic solvent and the use of the same in therapeutic and cosmetic formulations |
| 04/27/1989 | DE3835099A1 Pharmazeutische zusammensetzung Pharmaceutical composition |
| 04/26/1989 | EP0313463A2 Granulated compositions of polysaccharides, process for their preparation and their use |
| 04/26/1989 | EP0313328A1 Sustained-release formulations |
| 04/25/1989 | US4824986 Diethylenetriaminepentaacetic acid substituted with isothiocyanate or n-hydroxysuccinimide |
| 04/25/1989 | US4824938 Stabilized by maltose-containing polysaccharides |
| 04/25/1989 | US4824829 Spraying solution of antibiotic in alcohol with vegetable oil onto absorbent edible carriers, drying; animal feeds |
| 04/25/1989 | US4824678 Controlled-release medical preparations |
| 04/25/1989 | US4824674 Stable alpha-interferon dosage forms |
| 04/25/1989 | US4824669 Emulsions |
| 04/25/1989 | US4824664 Effervescent couples, histamine H2 -antagonist effervescent compositions containing them and their preparation |
| 04/25/1989 | US4824659 Antibody conjugates |
| 04/25/1989 | CA1253078A1 Injection solution containing choline theophyllinate |
| 04/25/1989 | CA1253075A1 Compositions for the coating of food additives for feeding ruminants and food additives thus coated |
| 04/20/1989 | WO1989003210A1 Liquid ibuprofen compositions and methods of making them |
| 04/20/1989 | WO1989003206A1 Gelatin composition |
| 04/20/1989 | WO1989003205A1 Viscoelastic material for ophthalmic surgery |
| 04/19/1989 | EP0312423A2 Antiparasitic agents, processes for their production, and antiparasitic compositions, especially antimalerials containing these agents |
| 04/19/1989 | EP0312352A2 Cyclodextrin derivatives and processes for preparing same |
| 04/19/1989 | EP0312340A1 Use of carbomer in controlled-release formulations to enhance or increase the dissolution rate of poorly soluble pharmacologically active substances |
| 04/19/1989 | EP0312265A2 Adhesive compositions, controlled release compositions and transdermal drug delivery device |
| 04/19/1989 | EP0312212A1 Immobilization of bioactive substance on lipid composition containing modified lipid compound |
| 04/19/1989 | EP0312208A1 Gel formulations containing growth factors |
| 04/19/1989 | EP0312052A1 Intranasal administration of polypeptides in powdered form |
| 04/19/1989 | EP0311632A1 Surface active lactams. |
| 04/18/1989 | US4822823 Improved water solubility by adding cyclodextrin derivatives |
| 04/18/1989 | US4822785 Stabilized lactose, sodium chloride, lactose-sodium chloride aqueous solutions |
| 04/18/1989 | US4822777 Amphotericin B/cholesterol sulfate composition |
| 04/18/1989 | US4822773 Enhancement of absorption of drugs from gastrointestinal tract using choline ester salts |
| 04/18/1989 | US4822611 Hexose monosaccharide and ethyl alcohol in water |
| 04/18/1989 | US4822601 Mixture of sucrose fatty acid ester and acyl fatty acid lactylate ester |
| 04/18/1989 | CA1252723A1 Controlled-release medical preparations |
| 04/18/1989 | CA1252719A1 METHOD FOR THE PREPARATION OF CONJUGATES OF ADENINE-9- .beta.-ARABINOFURANOSIDE 5' MONOPHOSPHATE WITH LACTOSAMINATED HUMAN ALBUMIN, THE CONJUGATES OBTAINED AND THERAPEUTICALLY ACTIVE COMPOSITION CONTAINING THEM |
| 04/18/1989 | CA1252717A1 Buffered polyol-hormone mixture for use in chronic parenteral hormone administration |
| 04/18/1989 | CA1252712A1 Polyhydroxy polymer delivery systems |
| 04/12/1989 | EP0311473A1 Fluorinated derivate of amino acids, useful as tensioactive or cotensioactive agents, and preparations for biomedical use containing these derivatives |
| 04/12/1989 | EP0311067A1 Pharmaceutical composition for piperidinoalkanol-decongestant combination |
| 04/12/1989 | EP0311065A1 Implantable biodegradable drug delivery system |
| 04/12/1989 | EP0310999A1 Pharmaceutical composition for piperidinoalkanol derivatives |
| 04/12/1989 | EP0310903A2 Organosilicium compound thickener for oils |
| 04/12/1989 | EP0310716A1 A product, preparation and method for treating allergies |
| 04/12/1989 | EP0310645A1 Compounds useful particularly for radiotherapy or imaging of cancer. |
| 04/11/1989 | US4820724 Dual phase solvent carrier system |
| 04/11/1989 | US4820720 Glycerol monolaurate and ethanol enhancers;controlled drug delivery |
| 04/11/1989 | US4820711 Method for treating actinic keratosis with cytotoxic agents |
| 04/11/1989 | US4820523 Pharmaceutical composition |
| 04/06/1989 | WO1989002922A1 Adheson variants |
| 04/06/1989 | WO1989002751A1 Pharmaceutical compositions of recombinant interleukin-2 and formulation processes |
| 04/06/1989 | WO1989002750A1 Pharmaceutical compositions of recombinant beta-interferon and formulation processes |
| 04/06/1989 | WO1989002742A1 Tablet for use in the treatment of progesterone deficiency |
| 04/06/1989 | WO1989002736A1 Siderophores as antiparasitic agents |
| 04/06/1989 | WO1989002735A1 Compositions comprising 1-oxo- or thiohydrocarbyl substituted azacycloalkanes |
| 04/06/1989 | WO1989002709A1 Oxygen removal |
| 04/05/1989 | EP0310476A1 Inhibitory or destructible composition of at least one unicellular living being containing fluor F- and lithium li+ |
| 04/05/1989 | EP0309863A2 Composition and method to release an immune reaction to GnRH and method for the immunosterilization of mammals |
| 04/05/1989 | EP0309624A1 Composition for enhancing percutaneous administration of medicine |
| 04/04/1989 | US4818771 Sustained release microbiocides |
| 04/04/1989 | US4818542 Polymer network containing active materials for controlled release |
| 04/04/1989 | US4818517 Drug, water-insoluble swellable polymer, water-soluble thickener |
| 04/04/1989 | CA1252087A1 Radioactive diagnostic agent, and non-radioactive carriers therefor |
| 04/04/1989 | CA1252049A1 Method for percutaneously administering metoclopramide |
| 04/04/1989 | CA1252048A1 Stabilized clear benzoyl peroxide compositions |
| 04/04/1989 | CA1252039A1 Aqueous non-aggressive anthelmintic pour-on formulations |
| 03/30/1989 | DE3830749A1 Arzneimittel in form von kuegelchen mit hohem arzneistoffgehalt und verfahren zu ihrer herstellung Drug in the form of beads with a high drug-content and process for their production |
| 03/30/1989 | DE3830245A1 Calcitonins |
| 03/30/1989 | DE3730556A1 Multilipid-based medicine |
| 03/29/1989 | EP0309404A2 Bioadhesive copolymer useful as a carrier in the administration of medicines by direct contact |
| 03/29/1989 | EP0309157A1 Sustained release etodolac |
| 03/29/1989 | EP0309051A1 Controlled porosity osmotic pump |
| 03/29/1989 | EP0308739A1 Antinflammatory pharmaceutical composition endowed with sustained effect for topical use |
| 03/29/1989 | EP0308665A2 5-Aminosalicylic acid salts and pharmaceutical preparations containing them |
| 03/29/1989 | EP0308436A1 New medicated ointment, process for its production, means of application using said ointment and production of said ointment. |
| 03/29/1989 | CN1031940A Trans-mucosal delivery formulations and method for preparation thereof |
| 03/28/1989 | US4816568 Stabilization of growth hormones |
| 03/28/1989 | US4816440 Interleukins, sodium laurate |
| 03/28/1989 | US4816263 Dosage form for treating cardiovascular diseases comprising isradipine |
| 03/28/1989 | US4816247 For injections |
| 03/28/1989 | CA1251890A1 Macroporous bead polymers, a process for their preparation and their use |
| 03/28/1989 | CA1251734A1 Stabilized injectable solutions of piroxicam |
| 03/28/1989 | CA1251731A1 Sustained release tablets and method for preparation thereof |
| 03/23/1989 | WO1989002474A1 Method for diagnosis of cancer diseases |
| 03/23/1989 | WO1989002445A1 Water insoluble derivatives of hyaluronic acid |
| 03/23/1989 | WO1989002279A1 Trans-mucosal delivery formulations and a method for preparation thereof |
| 03/23/1989 | DE3830494A1 Water-soluble monoesters as solubilisers for pharmacological agents and pharmaceutical auxiliaries |
| 03/22/1989 | EP0308238A1 Stable lyophilized formulations containing growth factors |
| 03/22/1989 | EP0308208A1 Modified antibody conjugates with enhanced clearance |
| 03/22/1989 | EP0308181A1 Trans-mucosal delivery formulations and a method for preparation thereof |